Nektar Therapeutics
NKTR
#8923
Rank
C$0.14 B
Marketcap
$0.78
Share price
-8.09%
Change (1 day)
-44.23%
Change (1 year)

P/S ratio for Nektar Therapeutics (NKTR)

P/S ratio as of April 2025 (TTM): 1.06

According to Nektar Therapeutics 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.71. At the end of 2024 the company had a P/S ratio of 1.78.

P/S ratio history for Nektar Therapeutics from 2001 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20241.7848.73%
20231.20-74.08%
20224.61-81.14%
202124.522.68%
202019.9-40%
201933.2595.41%
20184.78-84.36%
201730.6169.61%
201611.314.76%
20159.88-2.52%
201410.114.13%
20138.88-15.6%
201210.517.45%
20118.9617.28%
20107.64-36.81%
200912.1112.06%
20085.70151.25%
20072.27-64.43%
20066.38-44.22%
200511.4-23.68%
200415.0108.11%
20037.2052.09%
20024.73-64.13%
200113.2

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
4.81 355.01%๐Ÿ‡บ๐Ÿ‡ธ USA
2.07 95.92%๐Ÿ‡บ๐Ÿ‡ธ USA
3.20 202.83%๐Ÿ‡บ๐Ÿ‡ธ USA
0.6932-34.45%๐Ÿ‡บ๐Ÿ‡ธ USA
3.97 275.41%๐Ÿ‡ฌ๐Ÿ‡ง UK
1.17 10.66%๐Ÿ‡บ๐Ÿ‡ธ USA
3.15 198.24%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
4.20 297.23%๐Ÿ‡บ๐Ÿ‡ธ USA